BMS/Furlough? No!
Executive Summary
Bristol-Myers Squibb's Richard Furlaud is not "departed" from the company as incorrectly reported by "The Pink Sheet" (Sept. 17, T&G-12). Furlaud, formerly the chairman of Squibb, is now president of the combined BMS and holds a board position through 1993. He stepped down from a transition role in charge of the merged drug businesses earlier this summer.